TEAS RF New Application

AXOVANT GENE THERAPIES

Axovant Sciences GmbH

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88563665
Filing Date: 08/02/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88563665
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\885\636\88563665\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT AXOVANT GENE THERAPIES
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the wording "AXOVANT" in lower case letters, with the "X" and "O" in stylized lettering, above the wording "GENE THERAPIES".
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 382 x 110
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Axovant Sciences GmbH
*STREET Viaduktstrasse 8
*CITY Basel
*COUNTRY Switzerland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
4051
LEGAL ENTITY INFORMATION
TYPE gesellschaft mit beschränkter haftung (gmbh)
STATE/COUNTRY WHERE LEGALLY ORGANIZED Switzerland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 01565/2019
       FOREIGN APPLICATION
       COUNTRY
Switzerland
       FOREIGN FILING DATE 02/05/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
FILING BASIS SECTION 44(e)
       FOREIGN REGISTRATION
       NUMBER
733003
       FOREIGN REGISTRATION
       COUNTRY
Switzerland
       FOREIGN REGISTRATION
       DATE
07/01/2019
       FOREIGN REGISTRATION
       EXPIRATION DATE
02/05/2029
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE reg-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0003.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0004.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0005.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0006.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0007.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0008.JPG
        STANDARD CHARACTERS
       OR EQUIVALENT
NO
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific and technological services and research and design relating thereto; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 01565/2019
       FOREIGN APPLICATION
       COUNTRY
Switzerland
       FOREIGN FILING DATE 02/05/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
FILING BASIS SECTION 44(e)
       FOREIGN REGISTRATION
       NUMBER
733003
       FOREIGN REGISTRATION
       COUNTRY
Switzerland
       FOREIGN REGISTRATION
       DATE
07/01/2019
       FOREIGN REGISTRATION
       EXPIRATION DATE
02/05/2029
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE reg-1-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0009.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0010.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0011.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0012.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0013.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0014.JPG
        STANDARD CHARACTERS
       OR EQUIVALENT
NO
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 01565/2019
       FOREIGN APPLICATION
       COUNTRY
Switzerland
       FOREIGN FILING DATE 02/05/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
FILING BASIS SECTION 44(e)
       FOREIGN REGISTRATION
       NUMBER
733003
       FOREIGN REGISTRATION
       COUNTRY
Switzerland
       FOREIGN REGISTRATION
       DATE
07/01/2019
       FOREIGN REGISTRATION
       EXPIRATION DATE
02/05/2029
       FOREIGN REGISTRATION FILE NAME(S)
       ORIGINAL PDF FILE reg-2-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf
       CONVERTED PDF FILE(S)
       (6 pages)
\\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0015.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0016.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0017.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0018.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0019.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\885\636\88563665\xml1\RFA0020.JPG
        STANDARD CHARACTERS
       OR EQUIVALENT
NO
ATTORNEY INFORMATION
NAME Allison Strickland Ricketts
ATTORNEY DOCKET NUMBER AXOV 1910273
FIRM NAME Fross Zelnick Lehrman & Zissu, P.C.
STREET 151 West 42nd Street, 17th Floor
CITY New York
STATE New York
COUNTRY United States
ZIP/POSTAL CODE 10036
PHONE 212-813-5900
EMAIL ADDRESS ricketts-docket@fzlz.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Joyce M. Ferraro
CORRESPONDENCE INFORMATION
NAME Allison Strickland Ricketts
FIRM NAME Fross Zelnick Lehrman & Zissu, P.C.
STREET 151 West 42nd Street, 17th Floor
CITY New York
STATE New York
COUNTRY United States
ZIP/POSTAL CODE 10036
PHONE 212-813-5900
*EMAIL ADDRESS ricketts-docket@fzlz.com; ferraro-docket@fzlz.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 825
*TOTAL FEE PAID 825
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88563665
Filing Date: 08/02/2019

To the Commissioner for Trademarks:

MARK: AXOVANT GENE THERAPIES (stylized and/or with design, see mark)

The literal element of the mark consists of AXOVANT GENE THERAPIES.
The applicant is not claiming color as a feature of the mark. The mark consists of the wording "AXOVANT" in lower case letters, with the "X" and "O" in stylized lettering, above the wording "GENE THERAPIES".
The applicant, Axovant Sciences GmbH, a gesellschaft mit beschränkter haftung (gmbh) legally organized under the laws of Switzerland, having an address of
      Viaduktstrasse 8
      Basel 4051
      Switzerland

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 01565/2019, filed 02/05/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of Switzerland registration number 733003, and/or proof of renewal, registered 07/01/2019 with a renewal date of __________ and an expiration date of 02/05/2029, and translation thereof, if appropriate.

Original PDF file:
reg-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf
Converted PDF file(s) (6 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6


       International Class 042:  Scientific and technological services and research and design relating thereto; pharmaceutical, biomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 01565/2019, filed 02/05/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of Switzerland registration number 733003, and/or proof of renewal, registered 07/01/2019 with a renewal date of __________ and an expiration date of 02/05/2029, and translation thereof, if appropriate.

Original PDF file:
reg-1-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf
Converted PDF file(s) (6 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6


       International Class 044:  Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 01565/2019, filed 02/05/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of Switzerland registration number 733003, and/or proof of renewal, registered 07/01/2019 with a renewal date of __________ and an expiration date of 02/05/2029, and translation thereof, if appropriate.

Original PDF file:
reg-2-20671224226-172914147_._certificate_for_AXOVANT_GENE_THERAPIES_Logo__F3142194x96B9E_.pdf
Converted PDF file(s) (6 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6




The applicant's current Attorney Information:
      Allison Strickland Ricketts and Joyce M. Ferraro of Fross Zelnick Lehrman & Zissu, P.C.      151 West 42nd Street, 17th Floor
      New York, New York 10036
      United States
      212-813-5900(phone)
      ricketts-docket@fzlz.com (authorized)
The attorney docket/reference number is AXOV 1910273.

The applicant's current Correspondence Information:
      Allison Strickland Ricketts
      Fross Zelnick Lehrman & Zissu, P.C.
      151 West 42nd Street, 17th Floor
      New York, New York 10036
      212-813-5900(phone)
      ricketts-docket@fzlz.com;ferraro-docket@fzlz.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 88563665
Payment Accounting Date: 08/02/2019

Serial Number: 88563665
Internet Transmission Date: Fri Aug 02 12:05:17 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-201908021205172
00597-88563665-620f53ac8db88d747d1567e0e
0a3a5550c95121b99a6a2c2dbddeacfac44b85a1
-DA-05172727-20190802120055517205

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed